Reference

References

Peer-reviewed primary literature, diagnostic criteria and guidelines cited throughout the chapter. DOIs and PMIDs were checked against PubMed and publisher records where they could be verified; where an identifier was uncertain it is omitted rather than guessed.

  1. Baloh RW
    Vertigo in patients with multiple sclerosis.
    Annals of Neurology. 1992;31(6):661–663.
  2. Berrettini S, De Vito A, Bruschini L, et al.
    Inner ear involvement in autoimmune diseases: MR imaging findings.
    American Journal of Neuroradiology. 2006;27(3):613–619.
  3. Bonaguri C, Orsoni JG, Zavota L, et al.
    Anti-cochlin antibodies in autoimmune inner ear disease.
    Laryngoscope. 2007;117(1):39–44.
  4. Bovo R, Aimoni C, Martini A
    Immune-mediated inner ear disease.
    Acta Oto-Laryngologica. 2006;126(10):1012–1021.
  5. Broughton SS, Meyerhoff WE, Cohen SB
    Immune-mediated inner ear disease: 10-year experience.
    Seminars in Arthritis and Rheumatism. 2004;34(4):544–548.
  6. Carlson ML, Link MJ, Wanna GB, Driscoll CL
    Management of sporadic vestibular schwannoma.
    Otolaryngologic Clinics of North America. 2015;48(3):407–422.
  7. Ciorba A, Bianchini C, Pelucchi S, Pastore A
    The impact of systemic autoimmune diseases on hearing.
    Autoimmunity Reviews. 2012;11(4):247–252.
  8. Harris JP, Ryan AF, Keithley EM
    Immune-mediated hearing loss: basic mechanisms and options for therapy.
    Acta Oto-Laryngologica. 1997;117(2):234–240.
  9. Haynes DS, Fina M, Schambaugh MA
    Cogan's syndrome: a retrospective review.
    Otology & Neurotology. 2002;23(1):84–88.
  10. Herdman SJ, Schubert MC, Das VE, Tusa RJ
    Recovery of dynamic visual acuity in bilateral vestibular hypofunction.
    Archives of Otolaryngology–Head & Neck Surgery. 2003;129(8):819–824.PMID: 12925338
  11. Keithley EM, Harris JP
    Emerging treatments for immune-mediated hearing loss.
    Expert Opinion on Biological Therapy. 2008;8(3):423–431.
  12. Koehler KR, Nie J, Longworth-Mills E, et al.
    Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells.
    Nature Biotechnology. 2017;35(6):583–589.doi:10.1038/nbt.3840PMID: 28459451
  13. Lempert T, Neuhauser H
    Epidemiology of vertigo, migraine and vestibular migraine.
    Journal of Neurology. 2009;256(3):333–338.
  14. Matteson EL, McDonald TJ, Lennon VA
    Audiovestibular dysfunction in patients with systemic autoimmune disease and the response to immunosuppressive treatment.
    Annals of the New York Academy of Sciences. 1997;830:254–265.
  15. McCabe BF
    Autoimmune sensorineural hearing loss.
    Annals of Otology, Rhinology & Laryngology. 1979;88(5 Pt 1):585–589.doi:10.1177/000348947908800501PMID: 496191
  16. Merchant SN, Adams JC, Nadol JB Jr
    Pathophysiology of Ménière's syndrome: are symptoms caused by endolymphatic hydrops?.
    Otology & Neurotology. 2005;26(1):74–81.
  17. Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB Jr, Bloch KJ
    Serum antibody to inner ear proteins in patients with progressive hearing loss: correlation with disease activity and response to corticosteroid treatment.
    JAMA. 1994;272(8):611–616.doi:10.1001/jama.1994.03520080053043PMID: 8057517
  18. Pathak S, Keen M, Clarke M
    A case of refractory autoimmune inner ear disease treated with etanercept.
    Rheumatology (Oxford). 2001;40(7):859–860.
  19. Ruckenstein MJ
    Autoimmune inner ear disease.
    Current Opinion in Otolaryngology & Head and Neck Surgery. 2004;12(5):426–430.PMID: 15377956
  20. Sweeney AD, Carlson ML, Wanna GB, Bennett ML, Haynes DS
    Cochlear implantation in autoimmune inner ear disease.
    Otology & Neurotology. 2015;36(6):1035–1040.
  21. Takagi D, Nakamaru Y, Maguchi S, et al.
    Otologic manifestations and management of Wegener's granulomatosis.
    Laryngoscope. 2002;112(9):1684–1690.
  22. Takeda T, Takeuchi T, Yoshikawa T, et al.
    Tocilizumab monotherapy in patients with refractory autoimmune inner ear disease: a preliminary study.
    Modern Rheumatology. 2017;27(4):665–669.
  23. Trune DR, Canlon B
    Corticosteroid therapy for hearing and balance disorders.
    Anatomical Record (Hoboken). 2012;295(11):1928–1943.